This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Save the date!
November 6–8, 2023Munich, Germany

Breakpoint Therapeutics GmbH


Breakpoint Therapeutics GmbH is a pre-clinical stage company dedicated to the discovery and development of novel oncology drugs that target the DNA damage response (DDR) in cancer cells.

Currently, we prosecute two next-generation oncology targets: DNA Polymerase Theta (PolQ) and Werner Helicase (WRN)